BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27263802)

  • 1. An evaluation of health care expenditures in Crohn's disease using the United States Medical Expenditure Panel Survey from 2003 to 2013.
    Bounthavong M; Li M; Watanabe JH
    Res Social Adm Pharm; 2017; 13(3):530-538. PubMed ID: 27263802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017.
    Bounthavong M; Suh K; Li M; Spoutz PM; Stottlemyer BA; Sepassi A
    Subst Abuse Treat Prev Policy; 2021 Oct; 16(1):80. PubMed ID: 34670580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
    Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs.
    Daniel GW; Malone DC
    J Manag Care Pharm; 2007 Mar; 13(2):142-54. PubMed ID: 17330975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expenditures and health status among adults with back and neck problems.
    Martin BI; Deyo RA; Mirza SK; Turner JA; Comstock BA; Hollingworth W; Sullivan SD
    JAMA; 2008 Feb; 299(6):656-64. PubMed ID: 18270354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
    Park KT; Ehrlich OG; Allen JI; Meadows P; Szigethy EM; Henrichsen K; Kim SC; Lawton RC; Murphy SM; Regueiro M; Rubin DT; Engel-Nitz NM; Heller CA
    Inflamm Bowel Dis; 2020 Jan; 26(1):1-10. PubMed ID: 31112238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental direct expenditure of treating asthma in the United States.
    Kamble S; Bharmal M
    J Asthma; 2009 Feb; 46(1):73-80. PubMed ID: 19191142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelines.
    Balu S
    Clin Ther; 2009 Jul; 31(7):1581-94. PubMed ID: 19695408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The insurance effect on prescription drug expenditures among the elderly: findings from the 1997 Medical Expenditure Panel Survey.
    Curtis LH; Law AW; Anstrom KJ; Schulman KA
    Med Care; 2004 May; 42(5):439-46. PubMed ID: 15083104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct cost burden among insured US employees with migraine.
    Hawkins K; Wang S; Rupnow M
    Headache; 2008 Apr; 48(4):553-63. PubMed ID: 18070057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.
    Kappelman MD; Rifas-Shiman SL; Porter CQ; Ollendorf DA; Sandler RS; Galanko JA; Finkelstein JA
    Gastroenterology; 2008 Dec; 135(6):1907-13. PubMed ID: 18854185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health Care Expenditures for Black and White US Adults Living Under Similar Conditions.
    Dean LT; Zhang Y; McCleary RR; Dawit R; Thorpe RJ; Gaskin D
    JAMA Health Forum; 2023 Nov; 4(11):e233798. PubMed ID: 37921746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015.
    Earla JR; Thornton JD; Hutton GJ; Aparasu RR
    J Manag Care Spec Pharm; 2020 Jun; 26(6):741-749. PubMed ID: 32463779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare expenditures and patient satisfaction: cost and quality from the consumer's perspective in the US.
    Fu AZ; Wang N
    Curr Med Res Opin; 2008 May; 24(5):1385-94. PubMed ID: 18387219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The direct and indirect cost burden of Crohn's disease and ulcerative colitis.
    Gibson TB; Ng E; Ozminkowski RJ; Wang S; Burton WN; Goetzel RZ; Maclean R
    J Occup Environ Med; 2008 Nov; 50(11):1261-72. PubMed ID: 19001952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of morbid obesity on medical expenditures in adults.
    Arterburn DE; Maciejewski ML; Tsevat J
    Int J Obes (Lond); 2005 Mar; 29(3):334-9. PubMed ID: 15685247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of illness of Crohn's disease.
    Bodger K
    Pharmacoeconomics; 2002; 20(10):639-52. PubMed ID: 12162753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National medical expenditures by smoking status in American adults: an application of Manning's two-stage model to nationally representative data.
    Swedler DI; Miller TR; Ali B; Waeher G; Bernstein SL
    BMJ Open; 2019 Jul; 9(7):e026592. PubMed ID: 31315859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates.
    Yelin E; Cisternas MG; Pasta DJ; Trupin L; Murphy L; Helmick CG
    Arthritis Rheum; 2004 Jul; 50(7):2317-26. PubMed ID: 15248233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental expenditure of treating hypertension in the United States.
    Balu S; Thomas J
    Am J Hypertens; 2006 Aug; 19(8):810-6; discussion 817. PubMed ID: 16876679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.